# Amplify Weight Loss Drug & Treatment ETF (THNR) — Holdings

THNR · NYSE · Fund

Canonical page: https://www.lighthorse.io/tickers/thnr/holdings

## Top holdings (as of Oct 13, 2026)

The 10 largest positions make up 63.6% of the fund. Want full holdings data source? [Register at AInvest](https://www.ainvest.com/etfs/NYSE-THNR/holdings/).

| Ticker | Weight |
| --- | --- |
| LLY | 10.62% |
| NVO | 8.84% |
| AMGN | 5.89% |
| ABBV | 5.71% |
| PFE | 5.60% |
| ROP | 5.54% |
| 1093 | 5.48% |
| GILD | 5.42% |
| AZN | 5.33% |
| MRK | 5.21% |

## Frequently Asked Questions

### What are the top holdings of THNR?

As of Oct 13, 2026, the largest positions in Amplify Weight Loss Drug & Treatment ETF are LLY (10.6%), NVO (8.8%), AMGN (5.9%), ABBV (5.7%), PFE (5.6%).

### How concentrated is THNR?

The 10 largest positions make up 63.6% of Amplify Weight Loss Drug & Treatment ETF, as reported on Oct 13, 2026.

---

Fund holdings are reported periodically and are a snapshot of a past date, not a live position list — what the fund holds today may differ. Weights cover only the largest positions shown, not the whole portfolio.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).